Canada· CA-DIN-02254506
ALDURAZYME
A laronidase product containing laronidase, registered in Canada by SANOFI-AVENTIS CANADA INC. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Laronidase is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Laronidase · ATC A16AB05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- LARONIDASE
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Country
- Canada (CA)
- ATC code
- A16AB05
- ATC class
- Laronidase
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for laronidase.
Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Laronidase · interactions on record
2 records
Same medicine, other countries
Laronidase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALDURAZYMESanofi B.V., Amsterdam
- United StatesALDURAZYMEGenzyme Corporation
- FinlandAldurazymeOrifarm Oy
- United KingdomAldurazyme 500units/5ml concentrate for solution for infusion vialsSanofi
- IrelandAldurazyme 100 U/ml concentrate for solution for infusionSanofi B.V.
- BelgiumAldurazyme 100 U/mlSanofi
- Japanラロニダーゼ（遺伝子組換え）サノフィ
- NetherlandsAldurazyme, concentraat voor oplossing voor i.v. infusie, 100U/ml, 5 mlGenzyme Europe BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aldurazyme
- Liechtenstein · Aldurazyme
- Norway · Aldurazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bba5e7eb-7645-4e6b-b183-2588408044f7 GET /v1/drugs/bba5e7eb-7645-4e6b-b183-2588408044f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02254506",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A16AB05",
"schedule": [
"Schedule D",
"Prescription"
],
"drug_code": "73940",
"strengths": [
"0.58 MG"
],
"ahfs_class": null,
"substances": [
"LARONIDASE"
],
"product_categorization": null
}See everything about laronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.